AREG and gastric cancer: A pro-tumorigenic role of ILC2s is the production of amphiregulin (AREG), a strong inhibitor of tumor responses that contributes to the recruitment and activation of regulatory T cells (Tregs) [116,117], also associated with a poor prognosis in breast [118], ovarian [119] and gastric cancers [117].